Tag Archives: nepicastat

Biotie Therapies Corp. released its H1-2013 interim report

19-8-2013 — /EuropaWire/ — Company Highlights April – June 2013 Biotie obtained an exclusive option to acquire Neurelis, Inc., a private specialty pharmaceutical company based in San Diego, CA, focused on developing products for epilepsy and other disorders of the central nervous … Read the full press release

Biotie Therapies started clinical study evaluating nepicastat in cocaine dependence

Turku, 29-5-2013 — /europawire.eu/ — Biotie Therapies today announced the start of a Phase 2 clinical study evaluating nepicastat (SYN117) in cocaine dependence. The National Institute on Drug Abuse (NIDA) at the US National Institutes of Health is funding the conduct … Read the full press release